Amedisys (AMED) | Stock Overview & Key Data

Amedisys Inc. | Mid-cap | Healthcare

$97.34

0.19%

| Amedisys Stock Comparison:

Amedisys vs HCA Healthcare Amedisys vs Tenet Healthcare Amedisys vs Ensign Group Amedisys vs Chemed Amedisys vs Option Care Health Amedisys vs S&P 500 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Amedisys Performance Comparison

Loading chart data...

Amedisys

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $96.92 High: $97.50

on June 17, 2025

52 Week Range

Low: $82.15 High: $98.95

on December 20, 2024

on July 26, 2024

All-Time High: $325.12 on January 25, 2021

Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights

Key Statistics

Market Cap i $3.2B

EPS i 2.71

P/E Ratio (TTM) i 35.85

Forward P/E i 19.01

P/B Ratio i 2.66

PEG Ratio i 19.01

Div. Yield i 0.00%

ROE i 7.15%

Beta i 0.944

Debt to Equity i 36.30

Financial Highlights

Profitability

Gross Margin i 43.84%

Operating Margin i 10.11%

Profit Margin i 3.79%

Returns and Earnings

Return on Assets (TTM) i 6.36%

Return on Equity (TTM) i 7.15%

EBITDA i $351.6M

Net Income (TTM) i $89.8M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Amedisys AMED	3.19B Mid-cap	3.31%	2.87%	5.07%	13.42%	7.08%	5.82%	-19.95%	-51.07%
HCA Healthcare HCA	89.30B Large-cap	-1.18%	-4.88%	12.22%	19.05%	23.79%	9.99%	114.43%	280.58%
Tenet Healthcare THC	15.27B Large-cap	-1.17%	-0.74%	28.31%	22.78%	31.16%	19.10%	210.42%	699.85%
Ensign Group ENSG	8.70B Mid-cap	1.90%	1.92%	17.57%	7.21%	14.87%	27.14%	104.38%	261.30%
Chemed CHE	8.06B Mid-cap	0.42%	-4.74%	-9.16%	2.26%	4.62%	2.30%	21.96%	20.86%
Option Care Health OPCH	5.17B Mid-cap	0.47%	-4.24%	-6.11%	35.64%	40.18%	13.38%	21.59%	123.48%

Ownership & Short Interest

Insider Ownership i 1.96%

Institutional Ownership i 93.04%

Shares Short i 2M

Short Ratio i 4.91

Short % of Shares Outstanding i 5.82%

Average 10-Day Volume i 332K

Average 90-Day Volume i 359K

Amedisys Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Amedisys would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is AMED's 52-week high and low?

In the last 52 weeks, Amedisys reached a high of $98.95 (on July 26, 2024) and a low of $82.15 (on December 20, 2024).

What is the market cap and P/E ratio for AMED?

Curious about Amedisys's size and valuation? Its market capitalization stands at 3.19B. When it comes to valuation, the P/E ratio (trailing twelve months) is 35.85, and the forward P/E (looking ahead) is 19.01.

Does AMED pay dividends? If so, what's the yield?

As for dividends, Amedisys isn't currently offering a significant yield, or that specific data isn't available right now. Its payout ratio, which shows how much of its earnings are paid as dividends, is 0.00%.

Who are Amedisys's main competitors or similar companies to consider before investing?

When looking at Amedisys, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
HCA Healthcare HCA	89.30B	Healthcare	Medical Care Facilities	9.99%	114.43%
Tenet Healthcare THC	15.27B	Healthcare	Medical Care Facilities	19.10%	210.42%
Ensign Group ENSG	8.70B	Healthcare	Medical Care Facilities	27.14%	104.38%
Chemed CHE	8.06B	Healthcare	Medical Care Facilities	2.30%	21.96%
Option Care Health OPCH	5.17B	Healthcare	Medical Care Facilities	13.38%	21.59%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Amedisys Inc.? (e.g., ROE, Debt/Equity)

To get a sense of Amedisys's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 7.15%, the Debt to Equity ratio from the most recent quarter is 36.30, and its Gross Profit Margin stands at 43.84%.

What is the recent revenue and earnings growth for AMED?

Looking at Amedisys's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by 4.10%, and quarterly earnings saw a YoY growth of 323.70%.

How much of AMED stock is held by insiders and institutions?

Wondering who owns Amedisys stock? Company insiders (like executives and directors) hold about 1.96% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 93.04%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.